BeiGene Alternatives & Competitors

12 companies similar to BeiGene — BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...

9 Series C $363.00M

Biopharma Biotechnology +2

CERo Therapeutics, Inc.

Tumor Cell Clearance Reimagined.

16 Series A $41.40M

South San Francisco, Unit...

Biotechnology Health and Wellness

NBE-Therapeutics AG

Next generation antibody drug conjugates

47 Series C

Basel, Switzerland

Biotechnology Health Care +1

Imvax, Inc.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...

24 Unknown $253.70M

Philadelphia, United Stat...

Biotechnology Health and Wellness +1

Track all BeiGene competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...

1 Series A $14.50M

Biotechnology Health Care +1

Gritstone bio

A lean biotech company aiming to develop revolutionary immune-based treatment for various...

33 Post Ipo Equity $604.10M

Emeryville, United States

Biotechnology Health Care +1

Takeda Oncology

We aspire to cure cancer, with inspiration from patients and innovation from everywhere.

1621

Cambridge, United States

Biopharma Biotechnology +1

Compare

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

4013 Acquired $12.56B

Santa Monica, United Stat...

Biotechnology Health Care +1

Massive Bio

AI-driven system connecting cancer patients to clinical trials in real time. Industrializi...

98 Series B $28.10M

Istanbul, Turkey

AI Big Data +5

Precirix

Precision radiopharmaceuticals

9 Series B $122.00M

Brussels, Belgium

NGM Biopharmaceuticals

Explorers on the frontier of life-changing science.

83 Growth $620.00M

South San Francisco, Unit...

Adcentrx Therapeutics

Merging Chemistry and Biology to Benefit the Lives of Patients

27 Series A $101.00M

San Diego, United States

Biotechnology Pharmaceutical

About BeiGene

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

Services

Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing

Target Customers

Cancer Patients, Healthcare Providers, Medical Researchers, Investors

Taxonomy

Life Sciences, Innovative Medicines, Cancer Treatment, Immuno-oncology, Hematology, Oncology, Targeted Therapy, Global Rebranding, Patient Partnerships, Pharmaceutical Development, Therapeutic Innovation, Global Healthcare, Redomiciliation, Shareholder Engagement

Business Model

B2B, B2C, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to BeiGene include Umoja Biopharma, CERo Therapeutics, Inc., NBE-Therapeutics AG, Imvax, Inc., Asylia Therapeutics. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to BeiGene based on industry overlap, target customers, and business model.

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

Don't just read about them. Follow them.

BounceWatch watches BeiGene and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

BeiGene Profile Umoja Biopharma Alternatives CERo Therapeutics, Inc. Alternatives NBE-Therapeutics AG Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BeiGene on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.